| dc.contributor.author | de Wolff, L | en_US |
| dc.contributor.author | Arends, S | en_US |
| dc.contributor.author | Pontarini, P | en_US |
| dc.contributor.author | Bombardieri, M | en_US |
| dc.contributor.author | Bowman, SJ | en_US |
| dc.contributor.author | Bootsma, H | en_US |
| dc.date.accessioned | 2023-11-30T10:41:36Z | |
| dc.date.available | 2021-09-29 | en_US |
| dc.date.available | 2023-11-30T10:41:36Z | |
| dc.date.issued | 2021 | en_US |
| dc.identifier.issn | 0392-856X | en_US |
| dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/92487 | |
| dc.format.extent | S100 - S106 | en_US |
| dc.relation.ispartof | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | en_US |
| dc.subject | primary Sjogren's syndrome | en_US |
| dc.subject | randomised controlled trial | en_US |
| dc.subject | outcome measures | en_US |
| dc.title | Development and performance of the Clinical Trials ESSDAI (ClinTrialsESSDAI), consisting of frequently active clinical domains, in two randomised controlled trials in primary Sjogren's syndrome | en_US |
| dc.type | Article | |
| pubs.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000731864300015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
| pubs.issue | 6 | en_US |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Published | en_US |
| pubs.volume | 39 | en_US |
| qmul.funder | Dissection of autoantigen specificity and pathogenicity of recombinant monoclonal antibodies generated from single lesional B-cells of Sjögren’s syndrome patients.::Arthritis Research UK | en_US |
